Informations:
Erreur:
ID
12805
Description
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT01506453
Lien
https://clinicaltrials.gov/show/NCT01506453
Mots-clés
Versions (1)
- 21/12/2015 21/12/2015 -
Téléchargé le
21 décembre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Lymphoblastic Leukemia NCT01506453
Eligibility Acute Lymphoblastic Leukemia NCT01506453
- StudyEvent: Eligibility
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT01506453
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
total xvi protocol
Item
participant is enrolled on total xvi
boolean
C0949634 (UMLS CUI [1])
age
Item
participant is 1 year of age or older
boolean
C0001779 (UMLS CUI [1])
neuropathic pain
Item
participant has symptoms of np/pn with onset no more than 7 days after one of the following vincristine doses: protocol week 1, week 2 (induction), week 7 (reinduction i), or week 17 (reinduction ii).
boolean
C0458960 (UMLS CUI [1])
treatment protocol
Item
patient is expected to receive 2 doses of vincristine in weekly intervals as outlined by the total xvi protocol while on study drug (i.e. no known dosage reductions or planned missed doses).
boolean
C0949634 (UMLS CUI [1])
compliance
Item
participant is able and willing to take oral medications.
boolean
C1321605 (UMLS CUI [1])
study subject participation status
Item
previous participation in this study
boolean
C2348568 (UMLS CUI [1])
participant is receiving gabapentin for another indication
Item
participant is receiving gabapentin for another indication at the time of diagnosis of np/pn or has received gabapentin previously.
boolean
C0060926 (UMLS CUI [1])
C0087111 (UMLS CUI [2])
C0087111 (UMLS CUI [2])
pregnancy test negative , Contraception
Item
pregnancy. female participants of childbearing potential must have documented negative urine or serum pregnancy test result not older than 7 days. male patients with reproductive potential will be counseled not to procreate during the study.
boolean
C0427780 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
impaired renal function
Item
impaired renal function: decreased egfr (<60ml/min/1.73m^2 as estimated by the revised schwartz equation)
boolean
C0151746 (UMLS CUI [1])
participant has allergy or other contraindication for either morphine or gabapentin therapy
Item
participant has allergy or other contraindication for either morphine or gabapentin therapy.
boolean
C0020517 (UMLS CUI [1])
C0026549 (UMLS CUI [2])
C0060926 (UMLS CUI [3])
C0026549 (UMLS CUI [2])
C0060926 (UMLS CUI [3])
informed consent
Item
inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
boolean
C0021430 (UMLS CUI [1])